Wedbush is out with its report today on Molina Healthcare MOH, lowering its PT from $45 to $30.
In a note to clients, Wedbush writes, "Overall, we believe Molina is favorably positioned going into some of the upcoming RFPs as it is a new or recent entrant in a number of cases; this compares to incumbent peers who are exposed to the risk of losing share as more insurers enter the market. Our PT of $30 is 18.6x our updated 2011E of $1.63."
Wedbush maintains Outperform on MOH.
Shares of MOH closed Monday at $25.69.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in